These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 18372512)

  • 1. [Classification and treatment of ovarian cancer].
    Sugiyama T; Kou T
    Gan To Kagaku Ryoho; 2008 Feb; 35(2):228-232. PubMed ID: 18372512
    [No Abstract]   [Full Text] [Related]  

  • 2. [Ovarian cancer].
    Bertelsen K; Knudsen JB
    Ugeskr Laeger; 2002 Jun; 164(23):3056-9. PubMed ID: 12082861
    [No Abstract]   [Full Text] [Related]  

  • 3. Ovarian cancer. Be aware of warning signs.
    Mayo Clin Health Lett; 2005 Oct; 23(10):1-3. PubMed ID: 16408343
    [No Abstract]   [Full Text] [Related]  

  • 4. [Importance of adequate staging in selecting the method of treatment in ovarian cancer].
    Pashkiavichius RI
    Vopr Onkol; 1979; 25(3):66-7. PubMed ID: 433208
    [No Abstract]   [Full Text] [Related]  

  • 5. The medical-surgical nurse's guide to ovarian cancer: part I.
    Bohnenkamp S; LeBaron V; Yoder LH
    Medsurg Nurs; 2007 Aug; 16(4):259-66; quiz 267. PubMed ID: 17907699
    [No Abstract]   [Full Text] [Related]  

  • 6. Ovarian carcinoma--perspective for the 1980s.
    Baker DP
    Tex Med; 1984 Jan; 80(1):35-8. PubMed ID: 6695343
    [No Abstract]   [Full Text] [Related]  

  • 7. [General rules for management of ovarian cancers].
    Tsuruchi N
    Nihon Rinsho; 2004 Oct; 62 Suppl 10():480-3. PubMed ID: 15535292
    [No Abstract]   [Full Text] [Related]  

  • 8. Ovarian cancer: diagnosis, staging, treatment.
    Girtanner RE
    Tex Med; 1979 Feb; 75(2):75-80. PubMed ID: 441967
    [No Abstract]   [Full Text] [Related]  

  • 9. A treatment selection protocol for recurrent ovarian cancer patients: the role of FDG-PET/CT and staging laparoscopy.
    Fagotti A; Fanfani F; Rossitto C; Lorusso D; De Gaetano AM; Giordano A; Vizzielli G; Scambia G
    Oncology; 2008; 75(3-4):152-8. PubMed ID: 18827492
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ovarian cancer--a challenging disease.
    Einhorn N
    Gynecol Oncol; 1996 Oct; 63(1):10-3. PubMed ID: 8898160
    [No Abstract]   [Full Text] [Related]  

  • 11. Fatigue in women receiving intraperitoneal chemotherapy for ovarian cancer: a review of contributing factors.
    Anderson NJ; Hacker ED
    Clin J Oncol Nurs; 2008 Jun; 12(3):445-54. PubMed ID: 18515243
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Diagnosis and treatment of malignant ovarian tumors 2005: recommendations of the Kommission Ovar of the AGO].
    Schmalfeldt B; du Bois A; Burges A; Emons G; Fink D; Gropp M; Hasenburg A; Jäger W; Kimmig R; Kiechle M; Kommoss F; Kreienberg R; Kuhn W; Lück HJ; Meier W; Münstedt K; Ortmann O; Pfisterer J; Richter B; Runnebaum I; Schröder W; Sehouli J; Tanner B; Wagner U; Weis J
    Zentralbl Gynakol; 2006 Feb; 128(1):11-7. PubMed ID: 16450281
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epithelial ovarian cancer: future prospects for treatment.
    Shelling AN; Cooke IE; Le Meuth VG; Ganesan TS
    N Z Med J; 1996 Apr; 109(1020):131-2. PubMed ID: 8649666
    [No Abstract]   [Full Text] [Related]  

  • 14. Ovarian Cancer.
    Jacobs A
    Clin Symp; 1996; 48(2):2-32. PubMed ID: 8718804
    [No Abstract]   [Full Text] [Related]  

  • 15. When your patient has ovarian cancer.
    Ivey CL
    RN; 1994 Nov; 57(11):26-31; quiz 32. PubMed ID: 7984877
    [No Abstract]   [Full Text] [Related]  

  • 16. Ankyrin repeat domain 1, ANKRD1, a novel determinant of cisplatin sensitivity expressed in ovarian cancer.
    Scurr LL; Guminski AD; Chiew YE; Balleine RL; Sharma R; Lei Y; Pryor K; Wain GV; Brand A; Byth K; Kennedy C; Rizos H; Harnett PR; deFazio A
    Clin Cancer Res; 2008 Nov; 14(21):6924-32. PubMed ID: 18980987
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Treatment of malignant ovarian tumors].
    Grigorova TM
    Akush Ginekol (Mosk); 1979 Dec; (12):7-10. PubMed ID: 394610
    [No Abstract]   [Full Text] [Related]  

  • 18. Second line platinum-based intraperitoneal chemotherapy for advanced ovarian cancer.
    Milczek T; Klasa-Mazurkiewicz D; Emerich J; Kobierski J
    Acta Obstet Gynecol Scand; 2009; 88(4):463-7. PubMed ID: 19235559
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cancer cell-expressed immunoglobulins: CA215 as a pan cancer marker and its diagnostic applications.
    Lee G
    Cancer Biomark; 2009; 5(3):137-42. PubMed ID: 19407368
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sorting through the complexities of ovarian cancer.
    Rosenberg PK
    J Am Osteopath Assoc; 1995 Jan; 95(1):28-30. PubMed ID: 7860365
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.